GEA : Aker BioMarine commissions GEA to design the world’s first krill protein pilot plant

Having recently been generally recognized as safe (GRAS) by an expert panel, INVI, a sustainably sourced krill protein hydrolysate and the final product from the pilot plant, is now ready to be marketed in the United States. Krill protein has a complete, well-balanced amino acid profile and protein content of over 90 percent. Hydrolysates are known to be well absorbed by the human body as a result of the hydrolysis that takes place in the process and is consequently well suited to use in functional foods.

Following extensive research into protein powder, Aker BioMarine has developed a production process that converts protein flour into high-quality protein hydrolysate powder for human consumption. In commissioning the pilot plant, which will expand production from the current lab-based operation into a scalable, industrial process with a capacity of 120 tons per year, Aker BioMarine will develop and sell commercial products and work with partners to create new market opportunities.